Anthim: Completed pivotal trial enrollment

Elusys completed enrollment of 280 adult volunteers in a double-blind, placebo-controlled, U.S. pivotal trial evaluating

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE